CClinicalTrials.gg
CompletedNCT00631605Updated Mar 3, 2009

Studies of Neuroendocrine and Energy Metabolism in Patients With Eating Disorders

An observational study in Anorexia Nervosa and Bulimia Nervosa, sponsored by National Taiwan University Hospital. Completed at 1 site in Taiwan. Per ClinicalTrials.gov, last updated 2009-03-03.

Sponsored by National Taiwan University Hospital · Observational

Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
112
Sex
All
01

Study summary

This study aims to investigate neuroendocrine, autonomic functioning, and energy metabolism in patients with eating disorder and their relationships with psychopathology of eating disorders (eating patterns, depression, and personality) in these patients.

Read the detailed description

The study subjects include female patients with DSM-IV diagnosis of AN (n = 30), BN (n = 60) and age-controled normal subjects (n = 30). They will receive a clinical interview and are asked to complete several self-administered questionnaires which included eating-related questionnaires, general psychological functioning scales and personality scales. After overnight fast, each subject undergoes a blood sample collection for neuroendocrine examination, body composition examination using BIA method, basal metabolic rate measurement by indirect calorimetry, and ECG in the morning between 0800 and 0900. Clinical patients would be asked to repeat filling the self-rating scales, weight and body fat measurement, as well as blood drawing again 2 months after treatment.

02

Conditions studied

  • Anorexia Nervosa
  • Bulimia Nervosa

Keywords

  • eating disorders
  • ghrelin
  • leptin
  • BIA
03

In context

Anorexia

411 studies on the registry are indexed under Anorexia; 67 are open to participants now.

This study's enrollment of 112 is above the median of 65 across 104 observational studies indexed under Anorexia.

Browse Anorexia studies →

Lead sponsor

National Taiwan University Hospital is the lead sponsor of 2,563 studies on the registry; 569 are open to participants now.

Of its 11 completed or terminated interventional studies of FDA-regulated products, 2 (18%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

patients with eating disorders and normal controls

Inclusion criteria

  • Subjects who fulfilled DSM-IV diagnosis of anorexia nervosa or bulimia nervosa
  • Normal controls

Exclusion criteria

Exclusion Criteria:

  • Any major psychiatric disorders
  • Use of psychoactive medications
  • Drug and alcohol abuse
  • Medical problems (cardiovascular condition and endocrine disorders)
05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
112 participants (actual)
Biospecimen retention
Samples without dna

Groups and cohorts

  • 1
  • 2
06

Study locations

1 site
  • National Taiwan University Hospital
    Taipei, Taiwan
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 3, 2009, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00631605
Lead sponsor
National Taiwan University Hospital
First posted
Mar 10, 2008
Start date
May 2007
Primary completion
Jan 2009
Completion
Jan 2009
Last update
Mar 3, 2009

Study contacts

Mei-Chih Tseng, MD, Msc
principal investigator · National Taiwan University Hospital

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion